Skip to main content

Table 1 Clinical characteristics and genotype distribution in patients with aseptic loosening

From: BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty

 

All

BCL-2 genotype

p-value

  

CC

CA

AA

 

n (%)

87

22 (25.28)

49 (56.32)

16 (18.4)

 

Age at implantation (y)

60.18 ± 13.14

58.14 ± 14.06

60.94 ± 13.72

60.69 ± 10.08

0.703

Age at replantation (y)

69.31 ± 10.27

67.41 ± 12.77

70.04 ± 9.81

69.69 ± 7.79

0.605

Gender

     

   Female (%)

60 (68.97)

12 (20.0)

35 (58.33)

13 (21.66)

0.182

   Male (%)

27 (31.03)

10 (37.04)

14 (51.86)

3 (0.11)

 

Weight (kg)

75.11 ± 17.11

75.88 ± 19.59

76.1 ± 16.65

71.13 ± 15.18

0.592

Height (cm)

166.80 ± 8.35

168.09 ± 6.91

166.77 ± 9.13

165.13 ± 7.95

0.563

BMI (kg/m_)

26.86 ± 5.07

26.74 ± 6.04

27.25 ± 4.92

25.9 ± 4.15

0.655

First cup with cement (n = 83)

     

   no

34 (40.96)

6 (17.65)

19 (55.88)

9 (26.47)

0.280

   yes

49 (59.04)

14 (28.57)

28 (57.14)

7 (14.29)

 

First stem with cement (n = 80)

     

   no

30 (37.5)

4 (13.33)

19 (63.33)

7 (23.33)

0.147

   yes

50 (62.5)

16 (32.0)

27 (54.0)

7 (14.0)

 

Acetabular defects (Paprosky) n = 60

     

   I

6 (10)

3 (50.0)

2 (33.33)

1 (16.66)

0.479

   II

23 (38.83)

5 (21.74)

12 (52.17)

3 (13.04)

 

   III

31 (51.66)

7 (22.58)

17 (54.84)

7 (22.58)

 

Femoral defects (Paprosky) n = 52

     

   1

4 (7.69)

4 (100)

0

0

0.377

   2

23 (44.23)

5 (21.74)

14 (60.87)

4 (17.39)

 

   3

25 (48.08)

8 (32.0)

12 (48.0)

5 (20.0)

 
  1. Data are numbers with percentages given in brackets and numbers with standard deviation, respectively. Categorical variables were analyzed by χ2 statistics. P values were calculated using ANOVA for continuous variables.